Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 222 Colorectal Neoplasms 196 Rectal Neoplasms 174 Stomach Neoplasms 116 Pancreatic Neoplasms 100 Neoplasm Metastasis 77 Colonic Neoplasms 59 Neoplasms 50 Esophageal Neoplasms 39 Triple Negative Breast Neoplasms 38 Nasopharyngeal Carcinoma 28 Biliary Tract Neoplasms 27 Cholangiocarcinoma 22 Gallbladder Neoplasms 20 Locally Advanced Rectal Cancer 17 Carcinoma, Hepatocellular 17 Adenocarcinoma 15 Gastrointestinal Neoplasms 13 Colorectal Cancer Metastatic 13 Head and Neck Neoplasms 12 Bile Duct Neoplasms 12 Adenocarcinoma Of Esophagus 12 Esophageal Squamous Cell Carcinoma 11 Breast Neoplasms, Male 11 Brain Neoplasms 11 Liver Neoplasms 10 Carcinoma, Renal Cell 10 Neuroendocrine Tumors 9 Unspecified Adult Solid Tumor, Protocol Specific 8 Squamous Cell Carcinoma of Head and Neck 8

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ampullary Adenocarcinoma × Capecitabine × Clear all

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡